What is new? Therapy with lipid lowering agents
Der Internist 38(11 Suppl Therapie): 1-8
1997
ISSN/ISBN: 0020-9554 PMID: 9403084 Document Number: 480066
Document emailed within 1 workday
Related Documents
Amarenco, P. 2001: Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction Neurology 57(5 Suppl 2): S35-S44Kokot, F.; Szczechowska, E. 1981: Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(13): 454-457
Wirebaugh, S.R.; Shapiro, M.L.; McIntyre, T.H.; Whitney, E.J. 1992: A retrospective review of the use of lipid-lowering agents in combination, specifically, gemfibrozil and lovastatin PharmacoTherapy 12(6): 445-450
Kuemmerle, H.P. 1981: Lipid-lowering agents and their meaning in the treatment of the fat metabolism-atherosclerosis functional circle International Journal of Clinical Pharmacology Therapy and Toxicology 19(7): 289-296
Gollapudi, A.K. 2008: Do lipid-lowering agents provide a greater reduction in cardiovascular events among patients with diabetes? Annals of Internal Medicine 149(11): 841; Author Reply 841-2
Pearson, T.A.; Laurora, I.; Chu, H.; Kafonek, S. 2000: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals Archives of Internal Medicine 160(4): 459-467
Gronowitz, S.; Herslöf, M.; Svenson, R.; Bondesson, G.; Magnusson, O.; Stjernström, N.E. 1978: Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compounds Acta Pharmaceutica Suecica 15(5): 337-360
Bondesson, G.; Hedbom, C.; Magnusson, O.; Stjernström, N.E. 1976: Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde Acta Pharmaceutica Suecica 13(1): 1-8
Kaffarnik, H.; Schneider, J. 1983: Lipid lowering therapy in the elderly Münchener Medizinische Wochenschrift 125(28): 663-665
Kastelein, J.J.P. 2003: The future of lipid-lowering therapy: the big picture Netherlands Journal of Medicine 61(5 Suppl): 35-39
Bonadei, I.; Vizzardi, E.; D'aloia, A.; Gelsomino, S.; De Cicco, G.; Lorusso, R.; Dei Cas, L. 2013: Aortic valve stenosis and lipid-lowering therapy: the state of the art Panminerva Medica 55(4): 391-395
Nordmann, A.; Martina, B.; Keller, U.; Battegay, E. 1998: Lipid lowering therapy: new pathophysiologic aspects and clinical implications Schweizerische Medizinische Wochenschrift 128(17): 665-670
Radermecker, R.P.; Scheen, A.J. 2010: How to optimize lipid-lowering therapy: do not forget patient's non-compliance Revue Medicale de Liege 65(5-6): 311-317
Auer, J.; Berent, R.; Weber, T.; Porodko, M.; Mayr, H.; Maurer, E.; Eber, B. 2001: Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents Wiener Medizinische Wochenschrift 151(1-2): 13-17
Barth, J.D. 1995: Pixel or death: experience from clinical trials assessing lipid lowering therapy Canadian Journal of Cardiology 11 Suppl C: 9c
Lancellotti, P.; Pierard, L.A.; Scheen, A.J. 2015: Acute Coronary Syndrome and Lipid-Lowering Therapy. Does the Improve-It Study make Any Difference? Revue Medicale de Liege 70(9): 450-455
Truppo, C.; Keller, V.A.; Reusch, M.Teresa.; Pandya, B.; Bendich, D. 2003: The effect of a comprehensive, mail-based motivational program for patients receiving lipid-lowering therapy Managed Care Interface 16(3): 35-40 62
Högberg, T.; Bondesson, G.; Stjernström, N.E. 1977: Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate Acta Pharmaceutica Suecica 14(2): 149-160
Praipaisarnkit, K.; Wongpraparut, N.; Pongakasira, R. 2014: Low-density lipoprotein cholesterol goal attainment among post myocardial infarction patients on lipid lowering therapy at Siriraj outpatient clinic Journal of the Medical Association of Thailand 97(Suppl 3): S147-S154
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19